Our Science – Liu Website

Yongmin Liu, M.D., Ph.D.

Laboratory of Cancer Biology and Genetics Carcinogen-DNA Interactions Section Staff Scientist Center for Cancer Research National Cancer Institute Building 37, Room 4032 Bethesda, MD 20892-4254 Phone:   301-435-7844 Fax:   301-402-0153 E-Mail:   yongminl@mail.nih.gov

Biography

Dr. Liu graduated from Qingdao University School of Medicine with a medical degree in 1987. In 1996, he received his Ph.D. degree in Oncology from Peking Union Medical School (PUMC) & Chinese Academy of Medical Science (CAMS) in Beijing, China. Dr. Liu had two postdoctoral internships, one in University of Texas Health Science at San Antonio and one at the Baylor College of Medicine, which focused on the mechanistic studies of HPV in human cancers and the AP-1 transcription factor as a cancer prevention target in breast cancer, respectively. Subsequently, between 2001 and 2007, Dr. Liu worked as a research fellow in the Laboratory of Comparative Carcinogenesis, CCR, NCI-Frederick. His work in that period of time focused on cancer prevention, particularly metabolic intervention of cancer. From 2007 to 2009, Dr. Liu was a research scientist in SAIC-Frederick, Inc. He is currently a staff scientist with Dr. Miriam Poirier in the Carcinogen-DNA Interactions Section in the Laboratory of Cancer Biology and Genetics.

Dr. Liu’s current studies mitochondrial toxicity induced by anti-retroviral drugs, and in particular, nucleoside reverse transcriptase inhibitors (NRTIs). The projects include: 1) structural and functional mitochondrial changes in patas monkey fetuses exposed to human-equivalent antiretroviral protocols during gestation; 2). Metabolic and bioenegetic consequences NRTIs exposures in cardiomyocytes and monkey tissues. 3). the use of chemopreventive agents in reversal of NRTI-induced mitochondrial toxicity.

This page was last updated on 2/27/2013.